An overview application of silver nanoparticles in inhibition of herpes simplex virus

References

• Lövestam G, Rauscher H, Roebben G, et al. Considerations on a definition of nanomaterial for regulatory purposes. Luxembourg; Publications Office; 2010.
   Google Scholar
• Kafshdooz T, Kafshdooz L, Akbarzadeh A, et al. Applications of nanoparticle systems in gene delivery and gene therapy. Artif Cells Nanomed Biotechnol. 2016;44:581–587.
   PubMed Web of Science ®Google Scholar
• Rai M, Kon K, Ingle A, et al. Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects. Appl Microbiol Biotechnol. 2014;98:1951–1961.
   PubMed Web of Science ®Google Scholar
• Yezhelyev MV, Gao X, Xing Y, et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 2006;7:657–667.
   PubMed Web of Science ®Google Scholar
• Sun Y, Mayers B, Xia Y. Transformation of silver nanospheres into nanobelts and triangular nanoplates through a thermal process. Nano Lett. 2003;3:675–679.
   Web of Science ®Google Scholar
• Panáček A, Kvitek L, Prucek R, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B. 2006;110:16248–16253.
   PubMed Web of Science ®Google Scholar
• Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science. 1998;281:2016–2018.
   PubMed Web of Science ®Google Scholar
• Wang S, Mamedova N, Kotov NA, et al. Antigen/antibody immunocomplex from CdTe nanoparticle bioconjugates. Nano Lett. 2002;2:817–822.
   Web of Science ®Google Scholar
• Mah C, Zolotukhin I, Fraites T, et al. Microsphere-mediated delivery of recombinant AAV vectors in vitro and in vivo. Mol Ther. 2000;1:S239.
   Google Scholar
• Pantarotto D, Partidos CD, Hoebeke J, et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol. 2003;10:961–966.
   PubMed Web of Science ®Google Scholar
• Majidi S, Sehrig ZF, Farkhani SM, et al. Current methods for synthesis of magnetic nanoparticles. Artif Cells Nanomed Biotechnol. 2016;44:722–734.
   PubMed Web of Science ®Google Scholar
• Nam J-M, Thaxton CS, Mirkin CA. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science. 2003;301:1884–1886.
   PubMed Web of Science ®Google Scholar
• Mahtab R, Rogers JP, Murphy CJ. Protein-sized quantum dot luminescence can distinguish between” straight” bent”, and” kinked” oligonucleotides. J Am Chem Soc. 1995;117:9099–9100.
   Web of Science ®Google Scholar
• Pacioni NL, Borsarelli CD, Rey V, et al. Synthetic routes for the preparation of silver nanoparticles. Silver nanoparticle applications. New York: Springer; 2015. p. 13–46.
   Google Scholar
• Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med. 2006;119:S3–S10.
   PubMed Web of Science ®Google Scholar
• Jana S, Pal T. Synthesis, characterization and catalytic application of silver nanoshell coated functionalized polystyrene beads. J Nanosci Nanotech. 2007;7:2151–2156.
   PubMed Web of Science ®Google Scholar
• Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010;28:580–588.
   PubMed Web of Science ®Google Scholar
• Galdiero S, Falanga A, Vitiello M, et al. Silver nanoparticles as potential antiviral agents. Molecules. 2011;16:8894–8918.
   PubMed Web of Science ®Google Scholar
• Henderson DA. Principles and lessons from the smallpox eradication programme. Bull World Health Organ. 1987;65:535.
   PubMed Web of Science ®Google Scholar
• Gaikwad S, Ingle A, Gade A, et al. Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int J Nanomed. 2013;8:4303.
   PubMed Web of Science ®Google Scholar
• Ge L, Li Q, Wang M, et al. Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int J Nanomed. 2014;9:2399.
   PubMed Web of Science ®Google Scholar
• Russell A, Path F, Sl FP, et al. Antimicrobial activity and action of silver. Prog Med Chem. 1994;31:351.
   PubMedGoogle Scholar
• Herizchi R, Abbasi E, Milani M, et al. Current methods for synthesis of gold nanoparticles. Artif Cells Nanomed Biotechnol. 2016;44:596–602.
   PubMed Web of Science ®Google Scholar
• Elliott C. The effects of silver dressings on chronic and burns wound healing. Br J Nurs. 2010;19: S32–6.
   PubMedGoogle Scholar
• Zhang H, Smith JA, Oyanedel-Craver V. The effect of natural water conditions on the anti-bacterial performance and stability of silver nanoparticles capped with different polymers. Water Res. 2012;46:691–699.
   PubMed Web of Science ®Google Scholar
• Kafshdooz T, Kafshdooz L, Akbarzadeh A, et al. Applications of nanoparticle systems in gene delivery and gene therapy. Artif Cells Nanomed Biotechnol, 2016;44:581–587.
   PubMed Web of Science ®Google Scholar
• Hu R, Li S, Kong F, et al. Inhibition effect of silver nanoparticles on herpes simplex virus 2. Genet Mol Res. 2014;13:7022–7028.
   PubMed Web of Science ®Google Scholar
• Alkhouri N, Zein NN. Protease inhibitors: silver bullets for chronic hepatitis C infection. Cleve Clin J Med. 2012;79:213–222.
   PubMed Web of Science ®Google Scholar
• Xiang D-x, Chen Q, Pang L, et al. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods. 2011;178:137–142.
   PubMed Web of Science ®Google Scholar
• Baram-Pinto D, Shukla S, Perkas N, et al. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem. 2009;20:1497–1502.
   PubMed Web of Science ®Google Scholar
• Sohrabi N, Valizadeh A, Farkhani SM, et al. Basics of DNA biosensors and cancer diagnosis. Artif Cells Nanomed Biotechnol. 2016;44:654–663.
   PubMed Web of Science ®Google Scholar
• Li Y, Leung P, Yao L, et al. Antimicrobial effect of surgical masks coated with nanoparticles. J Hosp Infect. 2006;62:58–63.
   PubMed Web of Science ®Google Scholar
• Feng Q, Wu J, Chen G, et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52:662–668.
   PubMed Web of Science ®Google Scholar
• Kalishwaralal K, BarathManiKanth S, Pandian SRK, et al. Silver nano – a trove for retinal therapies. J Control Release. 2010;145:76–90.
   PubMed Web of Science ®Google Scholar
• Alt V, Bechert T, Steinrücke P, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials. 2004;25:4383–4391.
   PubMed Web of Science ®Google Scholar
• Wei J, Khun E. Determination of critical coagulation concentration of silicon nanoparticles. Adv Mater Lett. 2014;5:2–5.
   Google Scholar
• Khandelwal N, Kaur G, Kumara N, et al. Application of silver nanoparticles in viral inhibition: a new hope for antivirals. Dig J Nanomater Biostruct. 2014;9:175.
   Web of Science ®Google Scholar
• Gottesman R, Shukla S, Perkas N, et al. Sonochemical coating of paper by microbiocidal silver nanoparticles. Langmuir. 2010;27:720–726.
   PubMed Web of Science ®Google Scholar
• Orlowski P, Tomaszewska E, Gniadek M, et al. Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS One. 2014;9:e104113.
   PubMed Web of Science ®Google Scholar
• O'Farrell N. Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes. Sex Transm Infect. 1999;75:377–384.
   PubMed Web of Science ®Google Scholar
• Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis. 1998;541–553.
   PubMed Web of Science ®Google Scholar
• Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes: J IHMF. 2004;11:24A–35A.
   PubMedGoogle Scholar
• Forrester A, Farrell H, Wilkinson G, et al. Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J Virol. 1992;66:341–348.
   PubMed Web of Science ®Google Scholar
• Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983;98:958–972.
   PubMed Web of Science ®Google Scholar
• Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73–83.
   PubMed Web of Science ®Google Scholar
• Abbasi E, Kafshdooz T, Bakhtiary M, et al. Biomedical and biological applications of quantum dots. Artif Cells Nanomed Biotechnol. 2016;44:885–891.
   PubMed Web of Science ®Google Scholar
• Esmaeili M, Bonyadi M, Dastranj A, et al. HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest. 2008;66:68–72.
   PubMed Web of Science ®Google Scholar
• Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–527.
   PubMed Web of Science ®Google Scholar
• Anari E, Akbarzadeh A, Zarghami N. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line. Artif Cells Nanomed Biotechnol. 2016;44:1410–1416.
   PubMed Web of Science ®Google Scholar
• Toda M, Rabkin SD, Martuza RL. Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. Hum Gene Ther. 1998;9:2177–2185.
   PubMed Web of Science ®Google Scholar
• Gedanken A, editor. Antibacterial, antiviral, and antibiofilms nanoparticles. 2010 3rd International Nanoelectronics Conference (INEC); 2010.
   Google Scholar